PMV Pharmaceuticals, Inc. beat EPS estimates 75% of the time across 4 reported quarters (3 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.38 | $-0.34 | +10.5% | Beat |
| Q22026 FY2026 | $-0.38 | $-0.41 | -7.9% | Miss |
| Q12026 FY2026 | $-0.41 | $-0.34 | +17.1% | Beat |
| Q42025 FY2025 | $-0.40 | $-0.34 | +15.0% | Beat |
Back to PMVP overview · PMVP holders · PMVP KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.